• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

86例血液透析患者贫血的研究(作者译)

[A study of anemia in 86 patients on hemodialysis (author's transl)].

作者信息

Serra A, Camps J, Morlans M, Olmos A, Carrera A, Soriano B, Rodríguez J A, Pelegrí A, Bartolomé J, Piera L

出版信息

Med Clin (Barc). 1981 May 10;76(10):439-43.

PMID:7242164
Abstract

Anemia is one of the complications of terminal chronic renal failure that may worsen with periodical hemodialysis because of residual blood losses in the dialyzers that may be significant if clotting occurs within the circulation system. The potential iron deficiency component of the anemia has been studied in 86 patients submitted to periodic hemodialysis by measurement of hemoglobin, serum iron, transferrin saturation, total iron binding capacity, and ferritin. The following correlations were investigated: degree of anemia and type of renal disease, months on hemodialysis and hemoglobin, months on hemodialysis and serum ferritin, and liters of blood transfused and serum ferritin. Statistically significant correlations were found between months on hemodialysis and hemoglobin, and between liters of blood transfused and serum ferritin. From the correlation between serum iron and ferritin the patients could be classified in three groups: 1, with either normal or low serum iron and ferritin, candidates to iron therapy; 2, with elevated serum iron and ferritin, needing no iron treatment; and 3, with unequal changes of serum iron and ferritin, in whom iron kinetic studies are indicated in order to discover the patents that may benefit from iron therapy.

摘要

贫血是终末期慢性肾衰竭的并发症之一,由于透析器中存在残余失血,如果循环系统内发生凝血,残余失血可能相当可观,因此定期血液透析可能会使贫血加重。通过测量血红蛋白、血清铁、转铁蛋白饱和度、总铁结合力和铁蛋白,对86例接受定期血液透析的患者贫血潜在的缺铁成分进行了研究。研究了以下相关性:贫血程度与肾脏疾病类型、血液透析月数与血红蛋白、血液透析月数与血清铁蛋白,以及输血升数与血清铁蛋白。在血液透析月数与血红蛋白之间,以及输血升数与血清铁蛋白之间发现了具有统计学意义的相关性。根据血清铁和铁蛋白之间的相关性,患者可分为三组:1. 血清铁和铁蛋白正常或偏低,适合进行铁治疗;2. 血清铁和铁蛋白升高,无需铁治疗;3. 血清铁和铁蛋白变化不一致,需要进行铁动力学研究以发现可能从铁治疗中受益的患者。

相似文献

1
[A study of anemia in 86 patients on hemodialysis (author's transl)].86例血液透析患者贫血的研究(作者译)
Med Clin (Barc). 1981 May 10;76(10):439-43.
2
Monitoring iron status in end-stage renal disease patients on hemodialysis.监测接受血液透析的终末期肾病患者的铁状态。
Saudi J Kidney Dis Transpl. 2007 Mar;18(1):73-8.
3
Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.静脉注射维生素C对伴有促红细胞生成素低反应性贫血和高铁蛋白血症的血液透析患者的影响。
Am J Kidney Dis. 2006 Apr;47(4):644-54. doi: 10.1053/j.ajkd.2005.12.025.
4
Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.转铁蛋白受体-铁蛋白指数与血液透析患者铁反应性常规指标之间的关联
Am J Kidney Dis. 2006 Jun;47(6):1036-44. doi: 10.1053/j.ajkd.2006.02.180.
5
Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.血清铁蛋白和转铁蛋白受体测量作为血液透析患者缺铁性贫血指标的可信度。
Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1158-62.
6
The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.右旋糖酐铁治疗血液透析患者缺铁的疗效。
Clin Nephrol. 1995 Oct;44(4):238-40.
7
Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.血清铁蛋白是血液透析患者发病和死亡的一个标志物。
Am J Kidney Dis. 2001 Mar;37(3):564-72.
8
A comprehensive vision for intravenous iron therapy.静脉铁剂治疗的全面展望。
Am J Kidney Dis. 2008 Dec;52(6 Suppl):S14-20. doi: 10.1053/j.ajkd.2008.09.003.
9
[Serum ferritin and iron therapy in patients treated with periodic hemodialysis].[接受定期血液透析患者的血清铁蛋白与铁疗法]
Quad Sclavo Diagn. 1982 Dec;18(4):454-62.
10
[Serum ferritin in renal insufficiency, hemodialysis and kidney transplantation].[肾功能不全、血液透析及肾移植中的血清铁蛋白]
Schweiz Med Wochenschr. 1978 Nov 25;108(47):1835-8.